Zobrazeno 1 - 10
of 204
pro vyhledávání: '"R R, Love"'
Publikováno v:
International Journal of Breast Cancer, Vol 2012 (2012)
Women in low- and middle-income countries (LMICs) have yet to benefit from recent advances in breast cancer diagnosis and treatment now experienced in high-income countries. Their unique sociocultural and health system circumstances warrant a differe
Externí odkaz:
https://doaj.org/article/870c52352b004b07a18a251c33bdaf70
Publikováno v:
American Journal of Public Health. 87:1190-1196
OBJECTIVES: The current study examined the relationship between chronic disease status and the receipt of cancer preventive services over a 3-year period. METHODS: Adults (n = 4320) cared for by 167 nonacademic physicians in 42 primary care group pra
Autor:
R R Love
Publikováno v:
Journal of Clinical Endocrinology & Metabolism. 80:1757-1760
In the face of an apparently increasing incidence of postmenopausal breast cancer, and with frustratingly limited gains in treatment, significant possibilities for widespread prevention of breast cancer must be vigorously explored. However, progress
Autor:
R. R. Love
Publikováno v:
Archives of Internal Medicine. 154:2585-2588
Autor:
R. R. Love
Publikováno v:
Archives of Internal Medicine. 153:2113-2117
Antithrombin III level, fibrinogen level, and platelet count changes with adjuvant tamoxifen therapy
Autor:
R. R. Love
Publikováno v:
Archives of Internal Medicine. 152:317-320
Autor:
R. R. Love
Publikováno v:
Archives of Internal Medicine. 151:1842-1847
Autor:
R. R. Love
Publikováno v:
Archives of Internal Medicine. 151:19-21
Publikováno v:
Journal of cancer education : the official journal of the American Association for Cancer Education. 14(2)
A questionnaire was administered to 42 subjects completing a one-year cancer chemoprevention trial (response rate = 69%, n = 29). The questionnaire assessed subjects' 1) previous study participation, 2) perceived benefits/barriers of participation, 3
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 7(11)
DFMO is an irreversible inhibitor of ornithine decarboxylase (ODC), the key enzyme in mammalian polyamine biosynthesis. The goal of this study was to determine the effects of DFMO 0.5 g/m2/day as a single oral dose on polyamine and ODC levels in rect